Protalix Biotherapeutics, Inc. (PLX)

2.015 -0.04 (-2.18%) USD  |  NYAM  |  Jan 15, 10:24
More

Protalix Biotherapeutics EBITDA Margin Estimates for Current Quarter

EBITDA Margin Estimates for Current Quarter Chart

View EBITDA Margin Estimates for Current Quarter for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin Estimates for Current Quarter Range, Past 5 Years

View EBITDA Margin Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin Estimates for Current Quarter Benchmarks

View EBITDA Margin Estimates for Current Quarter Benchmarks
Start Trial
OraSure Technologies, Inc. Upgrade
PAVmed, Inc. --
Denali Therapeutics, Inc. Upgrade
AIM ImmunoTech, Inc. --
Armata Pharmaceuticals, Inc. Upgrade